Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapy-Reference-Cited by-同舟云学术

Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapy

Published:2007-01-02 Issue:5 Volume:87 Page:521-527
ISSN:0803-5253
Container-title:Acta Paediatrica
language:en
Short-container-title:

Author:

Galluzzi F,Salti R,Bindi G,Pasquini E,Cauza C

Publisher

Wiley

Subject

General Medicine,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1651-2227.1998.tb01497.x/fullpdf

Reference31 articles.

1. Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty;Kappy;J Clin Endocrinol Metabol,1989

2. Six-year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH-dependent precocious puberty;Manasco;J Pediatr,1989

3. Long-term results of long acting luteinizing-hormone-releasing-hormone agonist in central precocious puberty;Swaenepoel;Horm Res,1991

4. Gonadotrophin-releasing hormone: its action and receptors;Clayton;J Endocrinol,1989

5. Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-dependent precocious puberty;Oerter;Acta Paediatr,1993

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Controversias en el manejo de la pubertad precoz;Anales Médicos de la Asociación Médica del Centro Médico ABC;2022

2. Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty;Annals of Pediatric Endocrinology & Metabolism;2021-12-31

3. First growth reference curves for Tunisian children and adolescents;Archives de Pédiatrie;2021-07

4. Long-term outcomes after gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty;PLOS ONE;2020-12-10

5. Triptorelin depot for the treatment of children 2 years and older with central precocious puberty;Expert Review of Clinical Pharmacology;2018-07-03